相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabis use and patterns of psychotic symptomatology in a longitudinal birth cohort
Nicole Cant et al.
NEW ZEALAND MEDICAL JOURNAL (2022)
Cannabis use in early psychosis is associated with reduced glutamate levels in the prefrontal cortex
Silvia Rigucci et al.
PSYCHOPHARMACOLOGY (2018)
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
Philip McGuire et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Comparing the effect of clozapine and risperidone on cue reactivity in male patients with schizophrenia and a cannabis use disorder: A randomized fMRI study
Marise W. J. Machielsen et al.
SCHIZOPHRENIA RESEARCH (2018)
Mismatch negativity: A simple and useful biomarker of N-methyl-D-aspartate receptor (NMDAR)-type glutamate dysfunction in schizophrenia
Michael Avissar et al.
SCHIZOPHRENIA RESEARCH (2018)
Polygenic risk scores for schizophrenia and bipolar disorder associate with addiction
Gunnar W. Reginsson et al.
ADDICTION BIOLOGY (2018)
Deficits in striatal dopamine release in cannabis dependence
E. van de Giessen et al.
MOLECULAR PSYCHIATRY (2017)
Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis
M. J. McHugh et al.
PSYCHOLOGICAL MEDICINE (2017)
Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
Jasmina Mallet et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Psychological symptomatology and impaired prepulse inhibition of the startle reflex are associated with cannabis-induced psychosis
Isabel Morales-Munoz et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Cannabis-associated psychosis: Neural substrate and clinical impact
R. M. Murray et al.
NEUROPHARMACOLOGY (2017)
Neurobiological underpinnings and modulating factors in schizophrenia spectrum disorders with a comorbid substance use disorder: A systematic review
Ana Adan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis
Tabea Schoeler et al.
PSYCHIATRY RESEARCH (2017)
Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: A preliminary study
Nehal P. Vadhan et al.
PSYCHIATRY RESEARCH (2017)
The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition
Siri Helle et al.
PSYCHIATRY RESEARCH (2017)
Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis
E. Foglia et al.
PSYCHOLOGICAL MEDICINE (2017)
Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors
Sagnik Bhattacharyya et al.
SCIENTIFIC REPORTS (2017)
Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use
Ahmed Mhalla et al.
ANNALS OF GENERAL PSYCHIATRY (2017)
Compromised External Validity: Federally Produced Cannabis Does Not Reflect Legal Markets
Daniela Vergara et al.
SCIENTIFIC REPORTS (2017)
Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis
Tabea Schoeler et al.
LANCET PSYCHIATRY (2017)
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls
Michelle S. Goodman et al.
BRAIN STIMULATION (2017)
Cannabis use in first episode psychosis: Meta-analysis of prevalence, and the time course of initiation and continued use
Hannah Myles et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2016)
Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia
Johannes Rentzsch et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2016)
Antipsychotic efficacy in psychosis with co-morbid cannabis misuse: A systematic review
Robin P. Wilson et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed
Margaret Haney et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids
E. Appiah-Kusi et al.
PSYCHOLOGICAL MEDICINE (2016)
Effect of high-potency cannabis on corpus callosum microstructure
S. Rigucci et al.
PSYCHOLOGICAL MEDICINE (2016)
Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study
Jennifer L. Seddon et al.
SCHIZOPHRENIA BULLETIN (2016)
Reduced Brain Cannabinoid Receptor Availability in Schizophrenia
Mohini Ranganathan et al.
BIOLOGICAL PSYCHIATRY (2016)
Human Laboratory Studies on Cannabinoids and Psychosis
Mohamed Sherif et al.
BIOLOGICAL PSYCHIATRY (2016)
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Suzanne H. Gage et al.
BIOLOGICAL PSYCHIATRY (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Brain GABA Levels Across Psychiatric Disorders: A Systematic Literature Review and Meta-Analysis of 1H-MRS Studies
Remmelt R. Schur et al.
HUMAN BRAIN MAPPING (2016)
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis
Anahita Bassir Nia et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males
Corinde E. Wiers et al.
NEUROPSYCHOPHARMACOLOGY (2016)
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence
Marco Colizzi et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Relation between cannabis use and subcortical volumes in people at clinical high risk of psychosis
Lisa Buchy et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2016)
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis
Arianna Marconi et al.
SCHIZOPHRENIA BULLETIN (2016)
Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study
Rashmi Patel et al.
BMJ OPEN (2016)
Opposite Cannabis-Cognition Associations in Psychotic Patients Depending on Family History
Ana Gonzalez-Pinto et al.
PLOS ONE (2016)
Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis
Tabea Schoeler et al.
LANCET PSYCHIATRY (2016)
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample
A. M. Auther et al.
ACTA PSYCHIATRICA SCANDINAVICA (2015)
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis
Lisa Buchy et al.
BMC PSYCHIATRY (2015)
Cognitive correlates of frontoparietal network connectivity 'at rest' in individuals with differential risk for psychotic disorder
S. C. T. Peeters et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date
Musa Basser Sami et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis
Sagnik Bhattacharyya et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Cannabis-Related Episodic Memory Deficits and Hippocampal Morphological Differences in Healthy Individuals and Schizophrenia Subjects
Matthew J. Smith et al.
HIPPOCAMPUS (2015)
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products
Ryan Vandrey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Cannabis Abuse Effects on Prepulse Inhibition in Patients With First Episode Psychosis in Schizophrenia
Isabel Morales-Munoz et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2015)
Brain volume in male patients with recent onset schizophrenia with and without cannabis use disorders
Laura Koenders et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2015)
Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample
Adam Winstock et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Cannabis: debated schizophrenia link
Matthew Large et al.
NATURE (2015)
Perspective: Be clear about the real risks
Matthew Hill
NATURE (2015)
GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC
Rajiv Radhakrishnan et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Further human evidence for striatal dopamine release induced by administration of a†9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Matthijs G. Bossong et al.
PSYCHOPHARMACOLOGY (2015)
Application of cross-species PET imaging to assess neurotransmitter release in brain
Sjoerd J. Finnema et al.
PSYCHOPHARMACOLOGY (2015)
Sensorimotor gating, cannabis use and the risk of psychosis
T. Winton-Brown et al.
SCHIZOPHRENIA RESEARCH (2015)
Altered cortical maturation in adolescent cannabis users with and without schizophrenia
Katherine A. Epstein et al.
SCHIZOPHRENIA RESEARCH (2015)
Neurocognitive and social cognitive predictors of cannabis use in first-episode psychosis
Chelsea Arnold et al.
SCHIZOPHRENIA RESEARCH (2015)
Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2015)
Associations of Cannabis and Cigarette Use with Depression and Anxiety at Age 18: Findings from the Avon Longitudinal Study of Parents and Children
Suzanne H. Gage et al.
PLOS ONE (2015)
Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis
Ruud van Winkel et al.
ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 10 (2014)
Dopaminergic Function in Cannabis Users and Its Relationship to Cannabis-Induced Psychotic Symptoms
Michael A. P. Bloomfield et al.
BIOLOGICAL PSYCHIATRY (2014)
Do reward-processing deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of physiological response to natural rewards and drug cues
Clifford M. Cassidy et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2014)
The effect of clozapine and risperidone on attentional bias in patients with schizophrenia and a cannabis use disorder: An fMRI study
Marise W. J. Machielsen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
Imaging glutamate in schizophrenia: review of findings and implications for drug discovery
E. M. P. Poels et al.
MOLECULAR PSYCHIATRY (2014)
Genetic predisposition to schizophrenia associated with increased use of cannabis
R. A. Power et al.
MOLECULAR PSYCHIATRY (2014)
Early phytocannabinoid chemistry to endocannabinoids and beyond
Raphael Mechoulam et al.
NATURE REVIEWS NEUROSCIENCE (2014)
Stress-Induced Dopamine Response in Subjects at Clinical High Risk for Schizophrenia with and without Concurrent Cannabis Use
Romina Mizrahi et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Characterizing cannabis-induced psychosis: A study with prepulse inhibition of the startle reflex
Isabel Morales-Munoz et al.
PSYCHIATRY RESEARCH (2014)
Prognosis of schizophrenia in persons with and without a history of cannabis use
E. Manrique-Garcia et al.
PSYCHOLOGICAL MEDICINE (2014)
Cannabis use and transition to psychosis in people at ultra-high risk
L. R. Valmaggia et al.
PSYCHOLOGICAL MEDICINE (2014)
Daily Use, Especially of High-Potency Cannabis, Drives the Earlier Onset of Psychosis in Cannabis Users
Marta Di Forti et al.
SCHIZOPHRENIA BULLETIN (2014)
Cannabis-Related Working Memory Deficits and Associated Subcortical Morphological Differences in Healthy Individuals and Schizophrenia Subjects
Matthew J. Smith et al.
SCHIZOPHRENIA BULLETIN (2014)
Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia
David W. Volk et al.
SCHIZOPHRENIA RESEARCH (2014)
Change in cannabis use in the general population: A longitudinal study on the impact on psychotic experiences
W. A. van Gastel et al.
SCHIZOPHRENIA RESEARCH (2014)
Early somatosensory processing in individuals at risk for developing psychoses
Florence Hagenmuller et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2014)
Gone to pot - a review of the association between cannabis and psychosis
Rajiv Radhakrishnan et al.
FRONTIERS IN PSYCHIATRY (2014)
Trajectories of symptom dimensions in short-term response to antipsychotic treatment in patients with a first episode of non-affective psychosis
J. M. Pelayo-Teran et al.
PSYCHOLOGICAL MEDICINE (2014)
The Endocannabinoid System and the Brain
Raphael Mechoulam et al.
ANNUAL REVIEW OF PSYCHOLOGY, VOL 64 (2013)
Combined Grey Matter VBM and White Matter TBSS Analysis in Young First Episode Psychosis Patients With and Without Cannabis Consumption
Sven Haller et al.
BRAIN TOPOGRAPHY (2013)
Effects of cannabis and familial loading on subcortical brain volumes in first-episode schizophrenia
Berend Malchow et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Effects of cannabis use on event related potentials in subjects at ultra high risk for psychosis and healthy controls
Mirjam J. van Tricht et al.
INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2013)
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia
Jenny Ceccarini et al.
NEUROIMAGE (2013)
Dopamine Response to Psychosocial Stress in Chronic Cannabis Users: A PET Study With [11C]-(+)-PHNO
Romina Mizrahi et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography Study
Rebecca Kuepper et al.
PLOS ONE (2013)
Cannabis abuse is associated with better emotional memory in schizophrenia: A functional magnetic resonance imaging study
Josiane Bourque et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2013)
Cannabis use and brain structural alterations of the cingulate cortex in early psychosis
Charlotte Rapp et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2013)
MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse
O. E. Onwuameze et al.
PSYCHOLOGICAL MEDICINE (2013)
Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia
K. A. Welch et al.
PSYCHOLOGICAL MEDICINE (2013)
Cannabis use, cognition and brain structure in first-episode psychosis
Paulo Jannuzzi Cunha et al.
SCHIZOPHRENIA RESEARCH (2013)
Alteration to hippocampal shape in cannabis users with and without schizophrenia
Nadia Solowij et al.
SCHIZOPHRENIA RESEARCH (2013)
The Neural Correlates of Mental Rotation Abilities in Cannabis-Abusing Patients with Schizophrenia: An fMRI Study
Stephane Potvin et al.
SCHIZOPHRENIA RESEARCH AND TREATMENT (2013)
Induction of Psychosis by Δ9-Tetrahydrocannabinol Reflects Modulation of Prefrontal and Striatal Function During Attentional Salience Processing
Sagnik Bhattacharyya et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
The Association between Cannabis Use and Earlier Age at Onset of Schizophrenia and other Psychoses: Meta-analysis of Possible Confounding Factors
Nicholas Myles et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Neural Mechanisms for the Cannabinoid Modulation of Cognition and Affect in Man: A Critical Review of Neuroimaging Studies
Sagnik Bhattacharyya et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Substance use and regional gray matter volume in individuals at high risk of psychosis
James M. Stone et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults
Martin Cohen et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2012)
History of cannabis use is not associated with alterations in striatal dopamine D-2/D-3 receptor availability
Paul R. A. Stokes et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Parietal Lobe Volume Deficits in Adolescents With Schizophrenia and Adolescents With Cannabis Use Disorders
Sanjiv Kumra et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2012)
Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of δ-9-tetrahydrocannabinol on midbrain and striatal function
S. Bhattacharyya et al.
MOLECULAR PSYCHIATRY (2012)
Endocannabinoid Signaling and Synaptic Function
Pablo E. Castillo et al.
NEURON (2012)
Chronic Δ9-Tetrahydrocannabinol Exposure Induces a Sensitization of Dopamine D2/3 Receptors in the Mesoaccumbens and Nigrostriatal Systems
Nathalie Ginovart et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Incidence of Schizophrenia and Other Psychoses in England, 1950-2009: A Systematic Review and Meta-Analyses
James B. Kirkbride et al.
PLOS ONE (2012)
Persistent cannabis users show neuropsychological decline from childhood to midlife
Madeline H. Meier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings
J. H. Meijer et al.
PSYCHOLOGICAL MEDICINE (2012)
Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome
A. M. Auther et al.
PSYCHOLOGICAL MEDICINE (2012)
Delayed preattentional functioning in early psychosis patients with cannabis use
Nicole Pesa et al.
PSYCHOPHARMACOLOGY (2012)
The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample
Murat Yuecel et al.
SCHIZOPHRENIA BULLETIN (2012)
Increased gray matter density in patients with schizophrenia and cannabis use: A voxel-based morphometric study using DARTEL
Thomas Schnell et al.
SCHIZOPHRENIA RESEARCH (2012)
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
F. M. Leweke et al.
TRANSLATIONAL PSYCHIATRY (2012)
An fMRI Study of Neuronal Activation in Schizophrenia Patients with and without Previous Cannabis Use
Else-Marie Løberg et al.
Frontiers in Psychiatry (2012)
Cannabis Use and Earlier Onset of Psychosis
Matthew Large et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Reduced Cortical Thickness as an Outcome of Differential Sensitivity to Environmental Risks in Schizophrenia
Petra Habets et al.
BIOLOGICAL PSYCHIATRY (2011)
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects
Ethan B. Russo
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Impact of cannabis use on thalamic volume in people at familial high risk of schizophrenia
Killian A. Welch et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex
C. J. Stagg et al.
JOURNAL OF PHYSIOLOGY-LONDON (2011)
Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study
Emma Barkus et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
Jose Alexandre S. Crippa et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Modulation of Auditory and Visual Processing by Delta-9-Tetrahydrocannabinol and Cannabidiol: an fMRI Study
Toby T. Winton-Brown et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Cerebellar white-matter changes in cannabis users with and without schizophrenia
N. Solowij et al.
PSYCHOLOGICAL MEDICINE (2011)
The Impact of Substance Use on Brain Structure in People at High Risk of Developing Schizophrenia
Killian A. Welch et al.
SCHIZOPHRENIA BULLETIN (2011)
The effects of cannabis use on neurocognition in schizophrenia: A meta-analysis
Rachel A. Rabin et al.
SCHIZOPHRENIA RESEARCH (2011)
Cannabis use and striatal D2 receptor density in untreated first-episode psychosis: An in vivo SPECT study
Gemma Safont et al.
SCHIZOPHRENIA RESEARCH (2011)
Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS)
A. James et al.
SCHIZOPHRENIA RESEARCH (2011)
Differential effects of chronic cannabis use on preattentional cognitive functioning in abstinent schizophrenic patients and healthy subjects
Johannes Rentzsch et al.
SCHIZOPHRENIA RESEARCH (2011)
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia
Beng-Choon Ho et al.
SCHIZOPHRENIA RESEARCH (2011)
Supply and demand for endocannabinoids
Bradley E. Alger et al.
TRENDS IN NEUROSCIENCES (2011)
Association Between Cannabis Use and Psychosis-Related Outcomes Using Sibling Pair Analysis in a Cohort of Young Adults
John McGrath et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Psychosis reactivity to cannabis use in daily life: an experience sampling study
Cecile Henquet et al.
BRITISH JOURNAL OF PSYCHIATRY (2010)
Cannabis use and progressive cortical thickness loss in areas rich in CB1 receptors during the first five years of schizophrenia
Monica Rais et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge
Paul R. A. Stokes et al.
NEUROIMAGE (2010)
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Sagnik Bhattacharyya et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Cannabinoid CB1 Receptor Immunoreactivity in the Prefrontal Cortex: Comparison of Schizophrenia and Major Depressive Disorder
Stephen M. Eggan et al.
NEUROPSYCHOPHARMACOLOGY (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Cannabis use and callosal white matter structure and integrity in recent-onset schizophrenia
Nienke Dekker et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2010)
Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuse
Thomas Wobrock et al.
PSYCHOPHARMACOLOGY (2010)
Modulation of Mediotemporal and Ventrostriatal Function in Humans by Δ9-Tetrahydrocannabinol A Neural Basis for the Effects of Cannabis sativa on Learning and Psychosis
Sagnik Bhattacharyya et al.
ARCHIVES OF GENERAL PSYCHIATRY (2009)
Comorbid substance abuse and brain morphology in recent-onset psychosis
Thomas Wobrock et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2009)
Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum
Matthijs G. Bossong et al.
NEUROPSYCHOPHARMACOLOGY (2009)
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway
Oliver D. Howes et al.
SCHIZOPHRENIA BULLETIN (2009)
Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005
Martin Frisher et al.
SCHIZOPHRENIA RESEARCH (2009)
Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use
Miguel Ruiz-Veguilla et al.
SCHIZOPHRENIA RESEARCH (2009)
Excessive brain volume loss over time in cannabis-using first-episode schizophrenia patients
Monica Rais et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia
Stephen M. Eggan et al.
ARCHIVES OF GENERAL PSYCHIATRY (2008)
Neural Basis of Δ-9-Tetrahydrocannabinol and Cannabidiol: Effects During Response Inhibition
Stefan J. Borgwardt et al.
BIOLOGICAL PSYCHIATRY (2008)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Delta(9)-tetrahydrocannabinol, cannabidiol and Delta(9)-tetrahydrocannabivarin
R. G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Potency of Delta(9)-THC and other cannabinoids in cannabis in England in 2005: Implications for psychoactivity and pharmacology
David J. Potter et al.
JOURNAL OF FORENSIC SCIENCES (2008)
Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis
Cheryl M. Corcoran et al.
SCHIZOPHRENIA RESEARCH (2008)
Cannabis use and brain structural alterations in first episode schizophrenia - A region of interest, voxel based morphometric study
Srihari S. Bangalore et al.
SCHIZOPHRENIA RESEARCH (2008)
Elevated plasma dopamine metabolites in cannabis psychosis
Malcolm B. Bowers et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients:: Impact of cannabis use
F. Markus Leweke et al.
SCHIZOPHRENIA RESEARCH (2007)
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa H. M. Moore et al.
LANCET (2007)
Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls
Johannes Rentzsch et al.
EXPERIMENTAL NEUROLOGY (2007)
Anterior cingulate grey-matter deficits and cannabis use in first-episode schizophrenia
Philip R. Szeszko et al.
BRITISH JOURNAL OF PSYCHIATRY (2007)
Human cannabinoid pharmacokinetics
Marilyn A. Huestis
CHEMISTRY & BIODIVERSITY (2007)
An experimental study of catechol-O-methyltransferase Val158Met moderation of Δ-9-tetrahydrocannabinol-induced effects on psychosis and cognition
Cecile Henquet et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse
Maria C. Jockers-Scheruebl et al.
NEUROSCIENCE LETTERS (2006)
Fatty acid relationships in former cannabis users with schizophrenia
S Monterrubio et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2006)
Dopamine modulation of state-dependent endocannabinoid release and long-term depression in the striatum
AC Kreitzer et al.
JOURNAL OF NEUROSCIENCE (2005)
Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up
J Stirling et al.
SCHIZOPHRENIA RESEARCH (2005)
Cannabis use predicts future psychotic symptoms, and vice versa
RF Ferdinand et al.
ADDICTION (2005)
Cortical inhibitory neurons and schizophrenia
DA Lewis et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction
DC D'Souza et al.
BIOLOGICAL PSYCHIATRY (2005)
Tests of causal linkages between cannabis use and psychotic symptoms
DM Fergusson et al.
ADDICTION (2005)
Cannabis and brain morphology in recent-onset schizophrenia
W Cahn et al.
SCHIZOPHRENIA RESEARCH (2004)
Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia
K Zavitsanou et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2004)
Causal association between cannabis and psychosis: examination of the evidence
L Arseneault et al.
BRITISH JOURNAL OF PSYCHIATRY (2004)
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
DC D'Souza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse
MC Jockers-Scherübl et al.
NEUROSCIENCE LETTERS (2004)
Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats
JF Cheer et al.
JOURNAL OF NEUROSCIENCE (2004)
Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients
MC Jockers-Scherübl et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2003)
Cannabis-sensitive dopaminergic markers in postmortem central nervous system: Changes in schizophrenia
B Dean et al.
BIOLOGICAL PSYCHIATRY (2003)
Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study
H Verdoux et al.
PSYCHOLOGICAL MEDICINE (2003)
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
L Arseneault et al.
BRITISH MEDICAL JOURNAL (2002)
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study
S Zammit et al.
BRITISH MEDICAL JOURNAL (2002)
Cannabis and neurological soft signs in schizophrenia: Absence of relationship and influence on psychopathology
G Bersani et al.
PSYCHOPATHOLOGY (2002)
Cannabis use and psychosis: A longitudinal population-based study
J van Os et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use
B Dean et al.
NEUROSCIENCE (2001)
The effects of adolescent cannabis use on educational attainment: a review
M Lynskey et al.
ADDICTION (2000)
分享论文
